SCHEMBL5688352

SCHEMBL5688352

C#CCOc1cc(CCC(=O)OCC)ccc1OC

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.48
CYP4A11 Q02928 1/20 0.48
PDE4B Q07343 2/20 0.47
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 3/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
APP P05067 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
CYP2B6 P20813 1/20 0.43
DRD2 P14416 1/20 0.43
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5958023 0.95 APP (0.48) CYP4F2CYP4A11LMNASMN1; SMN2KMT2A
SCHEMBL5685688 0.94 CYP4F2 (0.51) CYP4F2CYP4A11LMNAKMT2AAPP
SCHEMBL5688186 0.91 CYP4F2 (0.49) CYP4F2CYP4A11LMNAKMT2AMEN1
SCHEMBL5685717 0.88 TSHR (0.46) KMT2ACA12CA2CA9APP
SCHEMBL491276 0.86 CYP4F2 (0.59) CYP4F2CYP4A11LMNASMN1; SMN2KMT2A
SCHEMBL5688279 0.85 FFAR1 (0.56) PDE4BKMT2ACYP2B6MEN1
SCHEMBL5685684 0.82 APP (0.47) CYP4F2CYP4A11PDE4BLMNASMN1; SMN2
SCHEMBL5685284 0.82 CALM1 (0.57) CYP4F2CYP4A11LMNASMN1; SMN2KMT2A
SCHEMBL1871415 0.81 KDM4E (0.48) KMT2ACA12CA1CA2CA9
SCHEMBL6583603 0.81 APP (0.66) SMN1; SMN2KMT2AAPPCHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122065-A1 Amide compound and method of controlling plant disease with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 US disclosed
US-20060122064-A1 Amides and method for plant diseases control with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 US disclosed
EP-1640360-A1 AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-29 EP disclosed
EP-1577290-A1 AMIDE COMPOUND AND METHOD OF CONTROLLING PLANT DISEASE WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2005-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122065-A1 Amide compound and method of controlling plant disease with the same CBR3, C5, CLN6 CYP4F2 1959/4885CYP4A11 1016/4885PDE4B 4530/4885
US-20060122064-A1 Amides and method for plant diseases control with the same ARG1, ARGLU1, ARG2 CYP4F2 2186/4885CYP4A11 1192/4885PDE4B 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.